Phase 1 Narcolepsy Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
Narcolepsy
Jazz Pharmaceuticals8 enrolled4 locationsNCT06961266
Completed
Phase 1
A phase 1, randomized, open-label, single-center, pilot study to evaluate the food effect and pharmacokinetics of single oral doses of XW10172 and sodium oxybate in healthy adult subjects
Narcolepsy
XW Laboratories (Australia) Pty Ltd8 enrolled1 locationACTRN12619000962134
Completed
Phase 1
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of ascending multiple oral doses of XW10172 in healthy adult subjects
Narcolepsy
XW Laboratories (Australia) Pty Ltd24 enrolled1 locationACTRN12618001038280
Completed
Phase 1
A phase 1 study to evaluate the safety, tolerability and pharmacokinetics of ascending single oral doses of XW10172 in healthy adult subjects
Narcolepsy
XW Laboratories (Australia) Pty Ltd50 enrolled1 locationACTRN12618000127202